Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Medicus Pharma Ltd. Common Stock

MDCX

HealthcareNASDAQCA

$0.35

-$0.0236 (-6.32%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

MDCX

1Y-0.0236 (-6.32%)

Candles, volume, SMA 20, and SMA 50

O 0.3496H 0.359L 0.3281C 0.35Date Jun 5

MDCX

SMA 20 SMA 50 Vol 1.70MEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$7.71M

Volume?1.67M

Avg Volume?6.88M

52w Range$0.25 - $3.69

Beta?-0.46

Price Performance

+11.5%

$0.314 to $0.35

YTD

-77.1%

$1.53 to $0.35

-87.3%

$2.76 to $0.35

N/A

history unavailable

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEORaza Bokhari

IndustryBiotechnology

Employees12

IPO Date2024-11-15

CurrencyUSD

Websitemedicuspharma.com

Related stocks

Check out other names from the same Biotechnology industry as MDCX.

ALGS-

Aligos Therapeutics, Inc.

4.91USD

-8.05%

BRNS-

Barinthus Biotherapeutics plc

0.65USD

-6.95%

COEP-

Coeptis Therapeutics, Inc.

Century Therapeutics, Inc.

2.13USD

-3.18%

KPTI-

Karyopharm Therapeutics Inc.

9.08USD

+0.11%

SKYE-

Skye Bioscience, Inc.

0.73USD

-5.37%

TELO-

Telomir Pharmaceuticals, Inc. Common Stock

1.21USD

-4.72%